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Abstract
Surgery is the recommended and most effective means 
of preventing the recurrence of primary spontaneous 
pneumothorax (PSP). However, the conventional belief 
amongst most clinicians is that surgery should not be 
routinely offered to patients with an uncomplicated 
first episode of PSP. The view that surgery should be 
reserved for recurrent episodes of ipsilateral PSP is 
based on an apprehension regarding traumatic thoracic 
surgery combined with a perception that recurrences 
after a single episode of PSP are unlikely. Modern 
advances in minimally invasive thoracic surgery have 
now dramatically reduced the morbidity of PSP surgery. 
Such surgery is now safe, effective and causes minimal 
indisposition for patients. On the other hand, modern 
clinical data suggests that recurrence rate of PSP is 
perhaps much higher than previously assumed, with 
more than half of patients experiencing a second 
episode within several years of the first. With such new 
appreciations of the current situation, it is appropriate 
to now consider offering surgery to patients even after 
the first episode of PSP.
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Core tip: Traditional guidelines advise that surgery is 
unnecessary for patients suffering a first episode of 
primary pneumothorax. However, such thinking was 
based on an incomplete picture of the frequency of 
recurrence and on older, relatively traumatic surgical 
approaches. Today, advanced surgical techniques 
allow effective bullectomy and pleurodesis to be safely 
delivered with only minimal morbidity or inconvenience 
to patients. Evidence is also emerging that recurrence 
may be more common than previously believed. It is 
perhaps time to allow clinical practices to catch up with 
modern medicine, and to consider surgery even after a 
first episode of primary pneumothorax.
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SCOURGE OF PRIMARY 
PNEUMOTHORAX
Primary spontaneous pneumothorax (PSP) is one of 
the most common emergent conditions encountered 
by pulmonologists, thoracic surgeons and clinicians 
involved in acute care medicine. Officially, the reported 
incidence of PSP is said to be 18-28/100000 cases 
per annum for men and 1.2-6/100000 for women[1,2]. 
However, because PSP mainly affects younger people, 
the actual incidence amongst “high risk” age groups 
(adolescents and young adults) might be substantially 
higher still. In the authors’ experience, whenever a 
class of college students is asked if any of them or 
their friends has experienced a pneumothorax, there 
is almost invariably at least one hand that will go 
up. That is how common and important a condition 
pneumothorax is in real life. Indeed, one of the authors 
of this article has himself suffered from recurrent PSP.
Sadly, for the young patient being treated for PSP, 
the experience can be unpleasant. The air in the pleural 
space causes symptoms[3]. The increased relative 
collapsing/stretching of the partly deflated lung in a 
pneumothorax situation over-stimulates the visceral 
pleural stretch receptors causing the pain and discomfort 
felt. The partial deflation of the lung also means collapse 
of the small terminal airways and alveoli, while the 
relative compressibility/expansibility of the air in the 
pneumothorax acts like a “shock absorber” impeding the 
chest wall and diaphragm’s ability to efficiently inflate 
and deflate the lung, thus leading to dyspnea. In certain 
situations-notably tension and bilateral pneumothorax-
the patient’s life could be threatened by the physiological 
compromise. Even in less dramatic presentations, a 
patient’s circumstance can make the occurrence of PSP 
a potentially grave consideration - for example, if he/she 
needs to travel by air frequently or is a keen diver[2,3].
Once the patient is seen by a doctor for PSP, the 
treatment itself can be disagreeable. Depending on size of 
the pneumothorax and the presence of symptoms, acute 
management of a PSP can be achieved by conservative 
management (sometimes with so-called “oxygen therapy” 
as an adjunct)[4], or by active intervention-namely 
needle aspiration or chest drain insertion[2]. Conservative 
management and needle aspiration may entail a period 
of admission, observation and repeated attendances for 
review to exclude re-accumulation. Chest drain insertion 
can be a potentially traumatic experience: involving pain 
on insertion, during drainage and on removal[5-7].
It would therefore seem to make perfect sense that 
if a patient should ever suffer an episode of PSP efforts 
should be made to prevent it ever happening again. 
And to prevent recurrence, an effective solution has 
already been available for decades: surgery. However, 
despite the obvious need to prevent recurrence and 
the accessibility of the solution, the prevailing dogma 
in the medical world is that surgery is not offered 
for the first episode of PSP[2,8]. This is a view based 
essentially on two arguments: (1) the potential harm 
of surgery is not inconsiderable; and (2) the risk of 
recurrent PSP after a first episode is not high enough 
to justify exposing the patient to such potential harm.
This article seeks to re-examine these arguments 
in the light of more recent clinical evidence. In this 
article, we do not discuss the acute management of 
PSP. We advise adherence to the latest international 
guidelines for initial management[2,8]. Instead, we 
propose a challenge to traditionalist views on definitive 
management with strategies to prevent recurrence. 
The objective is to answer the question: is it time 
for clinicians to change the paradigm? With modern 
understanding and advances, should patients with a 
first episode of PSP now be routinely offered surgery?
TRADITIONAL VIEW OF SURGERY
Definitive management of PSP is considered after 
the patient’s acute presentation has been adequately 
resolved, and aims to prevent recurrence. In practice, 
recurrence prevention is achieved by achieving two 
things: (1) bleb excision; and (2) effecting pleurodesis. 
Subpleural blebs and bullae are found at the lung 
apices during surgery and on CT scanning in up to 
90% of cases of PSP and these blebs are thought 
to play a role in its occurrence[9,10]. In patients who 
suffer recurrent PSP after previous surgery, residual 
or incompletely excised blebs are believed to be the 
reason for recurrence in up to 70%[11]. It is therefore 
a firmly held belief amongst surgeons that effective 
removal of these blebs must form an essential part of 
any definitive PSP treatment.
Pleurodesis is to fuse the visceral and parietal pleura 
together, thereby obliterating the pleural space in which 
pneumothorax might recur. Such pleurodesis is created 
by triggering aseptic inflammation of the pleura, with 
the resulting fibrosis giving the required inter-pleural 
symphysis. This can be done using chemical agents, 
autologous blood or surgical trauma to induce the 
inflammation[2,12]. Of these methods, surgery is well 
established to be significantly more effective, hence 
guidelines recommend that other methods should 
only be used if a patient is either unwilling or unable 
to undergo surgery[2,8]. As PSP patients tend to be 
young and otherwise fit, surgery is the approach for 
definitive management in the vast majority of cases. 
Furthermore, surgery is the only feasible means for 
visualization and resection of the primary culprit lung 
blebs.
In terms of surgical approach used, however, open 
thoracotomy and pleurectomy is traditionally held 
to be the “gold standard”[13]. This approach said to 
provide the lowest recurrence rate (approximately 1%). 
However, open thoracotomy-involving a long incision 
typically 8-20 cm long and forcible spreading apart of 
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the ribs during the entirety of the operation-is one of 
the most painful of all surgical incisions[14-17]. Persistent 
dysesthetic burning pain or aching can occur in up to 
50%-70% of patients at two months or more after 
thoracotomy[15,16]. In 5% of these patients, the pain 
has been described as “severe and disabling”, and over 
40% of patients may still have some degree of pain at 
one year after surgery. In turn, such pain is well known 
to result in increased post-operative complications and 
reduced quality of life after surgery.
It is in such a context that current clinical practice 
guidelines tend to avoid use of surgery for patients 
with only a single episode of PSP. The trauma-not only 
physical but also perhaps psychologically-of receiving 
such major surgery for a generally benign disease 
was considered excessive if the recurrence rate is not 
high. The 2003 British Thoracic Surgery Guidelines 
for the management of spontaneous pneumothorax 
specifically refer to open thoracotomy as the “gold 
standard” for surgical management[13]. With this 
standard in mind, it is unsurprising that clinicians 
would be reluctant to offer surgery. This is reflected 
in those guidelines listing the indications for surgery 
to only be: second ipsilateral pneumothorax; first 
contralateral pneumothorax; synchronous bilateral 
spontaneous pneumothorax; tension pneumothorax; 
persistent air leak after chest drain insertion; and 
spontaneous haemothorax[2,13]. First episode PSP 
is deliberately excluded. In a similar context back 
in 2001, the oft-quoted American College of Chest 
Physicians Consensus Statement on the management 
of spontaneous pneumothorax explicitly states that 
“procedures to prevent the recurrence of a primary 
spontaneous pneumothorax should be reserved for the 
second pneumothorax occurrence”[8]. 
It is therefore evident that views on surgical 
indications are influenced by the perceived harm from 
surgery. Over the past decade or more since the above 
guidelines, the trauma from thoracotomy remains 
inescapable. What has changed, though, is the view 
of whether open thoracotomy remains the surgical 
approach of choice.
VIDEO-ASSISTED THORACIC SURGERY: 
THE NEW “GOLD STANDARD”?
Over the past 20 years, minimally invasive video 
assisted thoracic surgery (VATS) has been established 
to be a safe and effective alternative to open thoracotomy 
for the management of PSP[10,18]. 
Conventional VATS for PSP is performed using a 
3-port technique[18-20]. A 10 mm wound is used for 
placement of a video-thoracoscope, and two 10 mm 
wounds are further placed for insertion of instruments. 
Through these 3 small ports, any visible bullae, blebs or 
areas of frank emphysema-like changes on the visceral 
pleura are excised using a surgical staple-resection 
device. Pleurodesis is then induced by either rubbing of 
the parietal pleura using an abrasive material (usually 
a coarse synthetic mesh) or by stripping of the parietal 
pleural from the chest wall like peeling off wall-paper 
(pleurectomy). Although pleurectomy is said to achieve 
slightly lower recurrence rates than pleural abrasion, it 
is a more traumatic procedure for the patient, and often 
a combination of the two is used[2]. Post-operatively, a 
chest tube is kept in situ for 1-2 d to facilitate lung re-
expansion and maximize apposition of the visceral and 
parietal pleura. VATS has been fully established to be a 
safe operation, with a mortality risk well below 1%.
With VATS, not only are the small wounds more 
cosmetically appealing, but the avoidance of rib-
spreading and reduction of soft tissue trauma 
significantly decreases surgical morbidity. There has 
been an abundance of clinical evidence proving this. In 
a prospective randomised controlled trial, Waller et al[21] 
studied two groups of 30 patients undergoing surgery 
for pneumothorax by VATS and open pleurectomy. 
It was reported that in the VATS group, the post-
operative analgesic requirement, hospital stay and 
compromise in lung function were all less than in the 
thoracotomy group. In another randomized trial, Sekine 
et al[22] compared VATS with transaxillary pleurectomy 
and found that VATS caused less compromise to gas 
exchange, probably due to reductions in chest wall 
pain, chest wall deformity and peripheral atelectasis. 
Many other similar studies and case series have 
consistently demonstrated the advantage of VATS in 
terms of: less intra-operative blood loss, less post-
operative pain, shorter lengths of hospital stay, better 
cosmesis and fewer wound complications[23-25]. Such 
evidence was consolidated in a meta-analysis in 2004 
when Sedrakayan et al[26] found that in the treatment 
of pneumothorax, VATS was associated with shorter 
length of hospital stay and less use of analgesics than 
thoracotomy. A systematic review in 2008 further 
concluded that VATS offered reductions in length 
of hospital stay, analgesic requirements, and post-
operative pulmonary dysfunction[27].
In return for the lower morbidity, VATS does not 
compromise on the efficacy of the pleurodesis. There 
was an early scare when one early meta-analysis 
suggested recurrence rates following VATS could be 
higher than after open surgery[28]. However, a weakness 
of that paper was that 15 of the 29 studies included in 
the meta-analysis were reported prior to 1997[27]. In 
the last ten years VATS has been increasingly used for 
the treatment of pneumothorax and earlier outcomes 
may not reflect present results[29]. Furthermore, in a 
prospective randomised controlled trial, it was shown 
that surgical treatment failures tended to occur in 
patients having treatment for secondary spontaneous 
pneumothorax, so that that VATS would be superior 
to open surgery if PSP alone were considered[21]. 
Sawada et al[23] also found in a retrospective non-
randomised study for patients with PSP that there was 
no statistically significant difference between VATS or 
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surgery: does not reduce wound number or size; 
increases the cost, time and complexity of surgery; 
and has never been proven to offer any outcome 
advantages over VATS for treating PSP. Ten years after 
the introduction of the robotic systems, these have 
never fully been established as a mainstream option for 
PSP surgery.
To date, arguably the most significant advance 
has been a further evolution of VATS: Needlescopic 
VATS[34-36]. Compared to the 10 mm wide ports used 
for conventional VATS, Needlescopic VATS uses a 
video-thoracoscope and instruments only 2-3 mm 
in diameter, thereby greatly reducing the size of the 
ports. The tiny wounds ensure not only reduced pain, 
but cause less compression of the intercostal nerves 
during manipulation intra-operatively. Needlescopic 
VATS was first used for sympathectomy surgery 
to treat palmar hyperhidrosis and sympathectomy 
disorders, and has been shown to reduce pain and 
paresthesia compared to conventional VATS[18,35,36]. 
For PSP, when the patient comes to the operating 
theatre, there is typically already a chest drain in situ. 
Unless this is infected, that chest drain wound can be 
sterilized and used as an instrument port for insertion 
of a standard surgical staple-resection device to 
resect any lung blebs. In addition, one or two 2-3 mm 
ports are placed for the insertion of the needlescopic 
video-thoracoscope and a needlescopic grasping 
instrument[36]. Inside the chest, exactly the same 
procedure of bleb resection, pleurectomy and pleural 
abrasion can be performed as in conventional VATS. 
We have previously reported our preliminary results 
comparing the Needlescopic VATS approach used for 
68 pleurodesis procedures for PSP (53%), with the 
conventional VATS approach used for 61 (47%)[35]. 
No mortality or major complications occurred in all 
patients. Recurrence rates between the Needlescopic 
VATS and conventional VATS groups were similar at 
up to 60 mo (2.9% vs 8.2% respectively, P = 0.31). 
There was a strong trend for shorter mean length of 
hospital stay in the Needlescopic VATS group (P = 
0.07). Mean pain scores at rest and on movement 
were consistently lower in the Needlescopic VATS 
group on each day during the post-operative stay, 
although the differences failed to reach statistical 
significance. The mean time until patients resumed 
work was over 6 d shorter in the Needlescopic VATS 
group, although again this barely failed to reach 
statistical significance. On telephone interview, patients 
in the Needlescopic VATS group reported significantly 
better mean scores for satisfaction with surgical wound 
cosmesis (6.4 vs 4.9, P < 0.01), with the incisions 
becoming virtually completely invisible within a couple 
of weeks after surgery. Similar results have also been 
noted by other studies, which have found that patients 
receiving nVATS reported less residual neuralgia and 
better wound satisfaction[37,38]. The use of nVATS was 
also consistently shown to yield a low recurrence rate 
thoracotomy in terms of recurrence rates. The most 
recent systematic review concluded that VATS has been 
shown to be comparable to open pleurectomy in the 
treatment of spontaneous pneumothorax[27].
The combination of lowered morbidity with equivalent 
efficacy at preventing recurrence means that open 
thoracotomy should no longer be regarded as the first 
line approach for the surgical management of PSP[24-26]. 
Today, VATS has become the approach of choice by 
surgeons throughout the developed world, and it is 
rare to find traumatic open surgery being offered to 
young patients with a benign condition such as PSP. 
Compared to the 2003 version, the latest British 
Thoracic Surgery Guidelines for the management 
of spontaneous pneumothorax published in 2010 
pointedly no longer uses the words “gold standard” in 
relation to open thoracotomy[2,13]. Instead, it is very 
noticeable that when the latest guidelines advised 
surgical pleurodesis for specific circumstances (such 
as pregnancy), VATS is the only approach named and 
open thoracotomy is nowhere to be seen.
ADVANCES IN SURGERY FOR 
PNEUMOTHORAX
With VATS replacing open thoracotomy as the current 
surgical approach of choice, should thresholds for 
offering surgery to PSP patients remain so high? 
Over the years, there have actually already been a 
number of clinical series suggesting that surgery after 
a first episode of PSP may offer advantages over 
non-surgical management (Table 1). Nowadays, the 
answer is further swinging increasingly in favor of 
surgery because advances in the performance and 
understanding of surgical pleurodesis have emerged 
that further improve outcomes for PSP patients.
Needlescopic VATS for pneumothorax
Despite the acknowledged benefits of VATS in reducing 
post-operative pain and morbidity[19,20], it is not 
capable of completely eliminating pain. After VATS for 
pneumothorax, up to 20%-30% of patients can still 
experience discomfort for up to several years[30,31]. 
In Hong Kong, we have previously reported that 
52.9% of patients receiving VATS for PSP experienced 
paresthesia as a post-operative complication distinct 
from their wound pain after a median of 19 mo after 
surgery[18]. 
A number of alternative approaches have been 
suggested over the years. One is to perform pleuroscopy 
(also known as “medical thoracoscopy”) for talc 
powder poudrage to induce chemical pleurodesis[3,32]. 
However, this method has still never been shown to 
offer recurrence rates as low as proper surgery and is 
therefore only recommend for “patients who are either 
unwilling or too unwell to undergo a VATS procedure”[2,8]. 
Another approach is the use of robotic surgical systems 
for pneumothorax surgery[33]. However, robot assisted 
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of 2.8%-4.6% (after follow-up period of 8-36.9 mo), 
which is comparable to conventional VATS[35,37-39].
For patients with PSP, perhaps the greatest 
attraction of Needlescopic VATS is the low “cost” in 
terms of morbidity and cosmesis. With Needlescopic 
VATS, since the patient has a chest drain wound in situ 
already (which is used as a surgical port), having the 
surgery means only adding two tiny 2-3 mm wounds 
that become virtually invisible after a week. In return, 
the patient receives effective definitive therapy to allow 
a normal, fully active lifestyle virtually free from worry 
about future recurrence.
Another approach for minimizing trauma with VATS 
pleurodesis is to use a Single Port (or Uniportal) VATS 
approach[40-43]. This technique involves a 20-25 mm 
incision through which the video thoracoscope along 
with two roticulating instruments are used side-by-
side. Whether the reduction in number of incisions 
offsets the increase in overall length and trauma of 
incisions is a subject for future clinical study.
Table 2 summarizes the results of clinical studies 
evaluating the above “next generation” VATS 
approaches for the surgical treatment of pneumothorax.
Influences of post-operative analgesia
The whole reason for operating in PSP is to achieve 
pleurodesis, and for that there must be good 
apposition between the visceral and parietal pleura. 
To a certain degree, suction on the chest drain after 
surgery will help this - and for this reason, it is always 
advisable to maintain some negative pressure after 
any pleurodesis procedure (surgical or chemical) until 
the moment the chest tube is removed[44]. But the 
other key factor is for the patient to maintain good 
inspiratory effort to inflate the lung from within. Deep 
breathing exercises and use of an incentive spirometer 
are essential components of this. The better the lung 
expands, the better the inter-pleural contact-and in 
turn this should in theory lead to better pleurodesis 
and lower recurrence rates. If the patient is in pain 
after surgery, this will obviously affect the ability to 
breathe in deeply or use the incentive spirometer. 
Therefore, effective post-operative pain control is 
important for effective pleurodesis.
For post-operative analgesia, opiates are not 
preferred. These not only have a potentially negative 
effect of unwanted respiratory depression, but they 
can make a patient dizzy or nauseated and thereby 
reduce post-operative mobility and compliance with 
breathing exercises - negating the advantages that 
minimally invasive surgery should be achieving. With 
advanced VATS techniques for a relatively simple 
Table 1  Summary of the key studies on surgical definitive management after a first episode of spontaneous pneumothorax
Ref. No. of patients Chest drain 
duration
Length of stay Complications Follow-up Recurrence Cost Other
Schramel et 
al[64]
149 first episode 
PSP
VATS: 70
Chest drain: 79
(Both first 
and recurrent 
episode 
included)
(Both first 
and recurrent 
episode 
included)
(Both first 
and recurrent 
episode 
included)
Chest drain: 
96 ± 18 mo
VATS: 29 ± 10 
mo
1 yr: VATS 
(3%) < CD 
(19%)
2 yr: VATS 
(4%) < CD 
(22%)
VATS < Chest 
drain (total cost of 
1 hospital stay + 
waiting time)
Cost of treating 
recurrence: VATS 
similar to Chest 
drain
If waiting time (4.4 
d for VATS) not 
considered, cost NS
Chest drain patients, 
if have recurrence, 
were management 
by thoracotomy
Torresini et 
al[65]
70
Chest drain: 35
VATS: 35
VATS: 3.9 d 
Chest drain: 9 
d
VATS: 6 d
Chest drain: 
12 d
Prolonged air 
leak > 6 d:
VATS: 5.7%
Chest drain: 
11.4%
12 mo VATS: 2.8%
Chest drain: 
22.8% 
VATS: $1925
Chest drain: $2750
(also included cost 
of recurrence)
Secondary 
pneumothorax 
included 
Chest drain arm: 2
VATS arm: 4
Chou et al[67] VATS: 51 2 d (54%) 3 d (54%) No 38 mo 0 -
Margolis et 
al[68]
VATS: 156 - 2.4 ± 0.5 d No 2-96 mo 
(median: 62 
mo)
0 - Talc poudrage for 
all patients intra-op
Sawada et al[23] 281
Chest drain: 181
Thoracotomy: 13
VATS: 87
- Chest drain: 
14.5 d
Thoracotomy: 
22.2 d
VATS: 8.3 d
(P < 0.001)
- 13-163 mo 
(mean: 78.3 
mo)
Not specified 
for first 
episode cases
Chest drain: 
54.7%
Thoracotomy: 
7.7%
VATS: 10.3%
(P < 0.001)
(Thoracotomy 
vs VATS: P = 
0.61)
- Length of stay 
analysis included 
both first and 
recurrent episodes
Chen et al[69] 52
Chest drain: 22
VATS: 30
- VATS: 4.8
Chest drain: 
6.1 
(P = 0.034)
VATS: 6.7%
Chest drain: 
27.3%
(P = 0.058)
3-38 mo (mean 
16 mo)
VATS: 3.3%
Chest drain: 
22.7%
(P = 0.038)
Total cost of 1 
hospital stay
VATS: $1273
Chest drain: $865
All patients had 
failed initial needle 
aspiration
VATS: Video assisted thoracic surgery; PSP: Primary spontaneous pneumothorax.
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Influences of post-operative chest drainage
As noted above, negative pleural pressure following 
surgery facilitates better contact between the visceral 
and parietal pleura after pleurodesis, potentially 
contributing to better outcomes[44]. 
The traditional water seal chest drain systems 
require connection to an external suction source (either 
“wall” suction or a noisy air pump device) whenever 
negative pleural pressure is required. One the patient 
is connected via the chest drain to such an external 
suction source, he/she is essentially shackled as 
though a ball-and-chain were clamped on. This is not 
only inconvenient for the patient, but also detrimental 
to effective lung expansion exercises.
We now use a portable digital chest drainage system 
for all of our PSP patients who have received VATS[49,50]. 
This system is a small, portable box connected to 
a patient’s chest tube that has an internal, battery-
powered suction mechanism delivering any level 
of negative pressure set by the clinician. Even with 
negative pressure applied, the patient is free to mobilize 
even on the day of surgery. This complements the 
faster physical recovery expected of Needlescopic and 
Single Port VATS. The digital chest drain system has an 
in-built digital air flow monitor that accurately displays 
in real-time the flow of air coming out of the chest 
tube from the patient’s thorax, providing an objective 
quantification of any air leak after surgery. The reliability 
gives surgeons the confidence to remove drains after a 
zero air flow reading for just several hours, instead of 
waiting for the traditional 24 h of “no bubbling” via the 
water seal before removal. We have previously reported 
significantly reduced chest drain durations and lengths 
of stay for our patients using these new digital chest 
drain systems[49]. On the hand, the need for re-insertion 
of chest drains after removal is also lower with the 
digital systems-reflecting the greater reliability of a “no 
air leak” reading with the digital system when compared 
to the traditional water seal system.
When removing the chest drain, there is also a 
better appreciation nowadays of what is important. 
Clamping of the drain before removal is unnecessary, 
and neither is a period of disconnection from suction to 
an underwater seal[51,52]. Clinical research has shown 
zero benefit of the latter when compared to removal 
of chest tubes after continuous suction. Indeed, it is 
the authors’ worry that discontinuation of suction can 
allow sucking of a small volume of air in the tubing 
above the water seal back into the chest, thereby 
creating a small degree of inter-pleural separation that 
is undesirable after pleurodesis. Whether to remove 
the chest tube at the end of maximal inspiration or 
expiration is also probably not very important[53]. 
Instead, what is perhaps more important about chest 
drain removal is the use of a closing suture[52]. This 
prevents re-entry of air into the chest, stops leakage 
of fluid out, and also provides a better cosmetic result 
after healing of the chest drain wound. 
THE NATURAL HISTORY OF PRIMARY 
PNEUMOTHORAX REVISITED
The advances in surgery have made an operation 
much less intimidating for patients and the physicians 
looking after them. However, no matter how minimally 
invasive surgery becomes, there can be no justification 
for offering it unless the disease treated has a poor 
prognosis when managed non-surgically. In this 
regard, the magic figure so lovingly and blindly 
trusted by generations of medical students, clinicians 
and textbook authors over the years has been the 
mythical “30% chance of recurrence”[44,54]. In the mind 
of the average layman-or even clinician-this means 
that after a first episode of PSP, if the patient is given 
proper initial acute management (conservative, needle 
aspiration, or chest drain insertion) and is then left 
alone, there is a 70% chance that he will never have 
another episode again. In other words, if nothing is 
done, then more likely than not, that first episode 
is also the last. If that is the case, it is obvious that 
surgery should not be offered on the first episode. It 
was argued that only after the second episode did the 
risk of subsequent recurrences rise high enough to 
justify major surgery[54,55].
However, what this simplistic view fails to take into 
account is that such figures often do not state over 
what length of time patients were followed up for, and 
whether follow-up was complete. If a cohort of patients 
is followed up for an extended period of many years, it 
is intuitive that the accumulated recurrence rate after 
that period would be higher than if the cohort was 
only followed up for several months. For example, in 
one study the recurrence rate for 19 young patients 
with PSP who were treated conservatively was 
reported as being “26.3%”[56]. This figure is close to 
that mythical “30% chance of recurrence”. However, 
closer scrutiny reveals that follow-up times in such a 
cohort varied from as short as 0.4 years to 6.9 years. 
Of the recurrences, some occurred at over 12 mo 
after the first episode. It follows that if all patients had 
been followed up for long enough then the observed 
recurrence rate would have been higher.
In recent years, studies have shown that recurrence 
rates of spontaneous pneumothorax can exceed 50% 
in patients that have been followed up for up to 5 
years[3,57,58]. When patients are followed for 4 years 
the risk of recurrence of PSP is as high as 54%[2,59]. 
This is the figure now officially quoted in British 
Thoracic Society guidelines. This fact deserves careful 
consideration for a moment. This means that an 
18-year-old young man with a first episode of PSP will 
have an over 50% chance of having another episode 
before he reaches his 22nd birthday. He could be abroad 
studying or travelling on a long-haul flight when that 
recurrence happens. Even if he finds medical attention 
in time, he will have to undergo another painful (and 
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potentially risky) chest drain insertion. And during all 
this time before the recurrence, there will be the worry 
of when the recurrence will strike-a situation not unlike 
having the Sword of Damocles hanging overhead. 
The question that faces clinicians nowadays is 
therefore: if effective surgery can be performed with 
such low morbidity, and if recurrence is more likely 
than not, why not offer surgery even after the first 
episode of PSP? Why wait for the second episode with 
the inherent problems that brings when it is likelier the 
patient will have a recurrence than won’t?
ARE THERE ANY REMAINING EXCUSES 
NOT TO OFFER SURGERY?
Despite the lowered morbidity of surgery and the 
higher-than-expected recurrence rate, there are still 
some potential arguments against offering surgery for 
the first episode of PSP.
Alternative non-surgical means of pleurodesis
If one of the arguments in favor of surgical pleurodesis 
today is that the trauma and morbidity has been 
reduced, then one could presumably argue that any 
approach that is even less traumatic than surgery 
should be even better. Chemical pleurodesis is usually 
effected by means of injecting talc or antibiotics into 
the pleural space to trigger inflammation and then 
fibrosis. In the British Thoracic Society guidelines, 
tetracycline was recommended as the first line 
sclerosant therapy in both primary and secondary 
pneumothoraces[2]. However, it was expressly remarked 
that “the incidence of late recurrence is 10%-20% 
which is unacceptably high compared with surgical 
methods of pleurodesis”[60-62], and therefore that 
“chemical pleurodesis … should only be attempted if 
the patient is either unwilling or unable to undergo 
surgery”. Talc is generally considered a more powerful 
sclerosant than antibiotics, but even talc has been 
shown on meta-analysis of several trials to only yield 
“a success rate of 87%”[63], which is still inferior to 
surgical pleurodesis.
Moreover, it is arguable whether VATS in expert 
hands is really any more invasive than chemical 
pleurodesis. The well recognized complications of 
pain, adult respiratory distress syndrome (ARDS), and 
infection/empyema have all been explicitly mentioned 
in relation to chemical pleurodesis in the guidelines[2,13]. 
The British Thoracic Society guidelines conclude by 
predicting that the “advent of successful and well-
tolerated VATS surgery will lead to less use of surgical 
chemical pleurodesis with talc”.
Cost-effectiveness issue
It goes without saying that performing surgery will cost 
more than not performing surgery, simply because 
bringing any patient to the operating room incurs 
fees relating to manpower, hardware, anesthesia, 
surgical consumables, and so on. However, this must 
be balanced against the costs of prolonged drainage, 
managing recurrences, and treating complications 
related to prolonged drainage and recurrences. 
Whereas with conservative treatment, prolonged 
leakage means an indeterminable period of waiting for 
the leak to stop, after any operation for pneumothorax 
the length of chest drainage is usually very consistent 
and short (1-3 d). 
Schramel et al[64] compared 112 patients treated for 
first time or recurrent spontaneous pneumothorax by 
conservative therapy (pleural drainage or observation) 
with 97 similar patients treated by VATS. The authors 
found that VATS reduced the complication rate (29% 
vs 18%, P = 0.05), overall recurrence rate (27% vs 
4%, P = 0.001), chest drain duration (9.4 ± 6.9 d 
vs 4.4 ± 2.6 d, P < 0.0001), and length of hospital 
stay (13 ± 10 d vs 11 ± 4 d, P = 0.03). This in turn 
resulted in an overall cost savings of 44% if VATS 
was offered primarily instead of conservative therapy. 
In another similar study, Torresini et al[65] compared 
patients with spontaneous pneumothorax treated by 
pleural drainage alone (n = 35) vs those treated by 
VATS (n = 35). They found that recurrences occurred 
in 22.8% of the patients in the conservative group vs 
2.8% in the VATS group (2.8%). Mean chest drainage 
durations and lengths of hospital stay were 9 and 12 d 
respectively in the conservative group versus 4 and 6 d 
respectively in the VATS group. Average management 
costs per patient in the conservative and VATS groups 
were $2750.00 vs $1925.00 respectively. Such results 
suggest that offering surgery for the first episode of 
PSP may be cost-effective.
Inconsistency in results of VATS
Current guidelines advocating the use of VATS have 
nonetheless acknowledged that even after surgery there 
is a “recurrence rate of approximately 5%”[2]. Critics 
have pointed out that the results may not also be as 
good as reported. In some case series, the recurrence 
rate can be as high as 16.1% after VATS for PSP[11]. 
However, even in such series, the authors are quick to 
point out that recurrences are related to inexperience 
with VATS leading to overlooked blebs. With increasing 
experience, it is recognized that recurrence rates tend 
to drop[29].
In a systematic review in 2009, Chambers et al[66] 
it was noted that the available literature proved that 
“VATS has superior outcomes in terms of recurrence 
rates of pneumothorax (from 0% to 13% according 
to several studies for VATS vs 22.8% to 42% for tube 
thoracostomy alone), duration of chest tube drainage 
(CTD) (4.56 d vs 7.6 d) and mean hospital stay (from 
2.4 to 7.8 d vs 6 to 12 d for CTD) with first-episode PSP 
compared with conservative treatment”[66]. The authors 
only hesitated to make a more sweeping, categorically 
recommendation for VATS for all first episodes of PSP 
because one study alone in a pediatric population 
showed contradictory results[58]. In that study, it was 
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shown that morbidity from recurrent pneumothorax was 
higher if VATS was performed for the first episode than 
if it was only performed for recurrent episodes as per 
traditional practice. However, closer scrutiny reveals that 
in that study, the recurrence rate if VATS was performed 
for the first episode was a staggeringly high 29%. 
This would nowadays be regarded as unacceptable by 
most thoracic surgeons, and is probably a reflection of 
inexperience with VATS at the time. If a more typical 
recurrence rate had been encountered in this study, the 
conclusions of the systematic review would likely have 
been more in favor of VATS for the first episode of PSP.
CONCLUSION
When faced with a deadly or malignant disease for 
which surgery is the best chance of cure, there is 
little hesitation on the part of clinicians or patients to 
accept an operation-no matter how traumatic that 
operation may be. PSP is altogether different because 
it is benign and rarely life-threatening. Therefore, the 
consideration of whether or not to offer surgery is one 
of risks vs benefits.
Traditionally, the risks were directly related to the 
fact that surgery involved open thoracotomy, and 
that entailed considerable post-operative morbidity. 
On the other hand, the benefits were not perceived 
to be great because the chance of recurrence after 
the first episode of PSP was said to be “around 30%”. 
No reasonable person would want to have highly-
traumatic surgery to prevent a benign condition that 
would not recur in the majority of patients.
But today, the human “cost” of surgery (morbidity) 
has been dramatically reduced with VATS supplanting 
thoracotomy as the approach of choice for PSP 
therapy. It promises to be even further minimized as 
Needlescopic VATS is being offered, and improved 
understanding of post-operative analgesia and chest 
drainage is being used to refine clinical pathways after 
VATS for PSP. The intimidation factor of surgery is 
now lower than it has ever been. On the other hand, 
modern clinical data is gradually prompting a realization 
that the natural history of PSP is not as docile as 
previously thought: within a few years of a first episode, 
around half of all patients may have recurrence. That 
recurrence not only involves unpleasant symptoms 
and a modicum of danger, but also the possibility of 
repeated admission and unpleasant interventions. 
The risk-benefit consideration is therefore swinging 
decidedly in favor of a more aggressive approach to first 
episodes of PSP.
Based on currently available evidence, technology 
and surgical techniques, it is becoming increasingly 
difficult to justify not offering surgery for patients with 
a first episode of PSP.
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